CytoSorbents Corporation

NASDAQ: CTSO
Share price (11/21/24): $0.89
Market cap (11/21/24): $48.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration – amended

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Granahan Investment Management, LLC

Deliargyris Efthymios

Capponi Vincent

Mariani Peter J

Mariani Peter J

News Filter

Reports Third Quarter 2024 Financial and Operational Results

Other Events, Financial Statements or Exhibits

• the De Novo Medical Device Application for DrugSorb™-ATR Is Eligible for FDA Priority Review as an FDA Breakthrough Designated Device for This Indication

Material Definitive Agreement

Appoints Peter J. Mariani Chief Financial Officer

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission